FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100082467> ?p ?o ?g. }

• W2100082467 abstract "Trifunctional bispecific antibodies (trAb) are a special class of bispecific molecules recruiting and activating T cells and accessory immune cells simultaneously at the targeted tumor. The new trAb Ektomab that targets the melanoma-associated ganglioside antigen GD2 and the signaling molecule human CD3 (hCD3) on T cells demonstrated potent T-cell activation and tumor cell destruction in vitro. However, the relatively low affinity for the GD2 antigen raised the question of its therapeutic capability. To further evaluate its efficacy in vivo it was necessary to establish a mouse model.We generated the surrogate trAb Surek, which possesses the identical anti-GD2 binding arm as Ektomab, but targets mouse CD3 (mCD3) instead of hCD3, and evaluated its chemical and functional quality as a therapeutic antibody homologue. The therapeutic and immunizing potential of Surek was investigated using B78-D14, a B16 melanoma transfected with GD2 and GD3 synthases and showing strong GD2 surface expression. The induction of tumor-associated and autoreactive antibodies was evaluated.Despite its low affinity of approximately 10(7) M(-1) for GD2, Surek exerted efficient tumor cell destruction in vitro at an EC(50) of 70 ng/ml [0.47 nM]. Furthermore, Surek showed strong therapeutic efficacy in a dose-dependent manner and is superior to the parental GD2 mono-specific antibody, while the use of a control trAb with irrelevant target specificity had no effect. The therapeutic activity of Surek was strictly dependent on CD4(+) and CD8(+) T cells, and cured mice developed a long-term memory response against a second challenge even with GD2-negative B16 melanoma cells. Moreover, tumor protection was associated with humoral immune responses dominated by IgG2a and IgG3 tumor-reactive antibodies indicating a Th1-biased immune response. Autoreactive antibodies against the GD2 target antigen were not induced.Our data suggest that Surek revealed strong tumor elimination and anti-tumor immunization capabilities. The results warrant further clinical development of the human therapeutic equivalent antibody Ektomab." @default.
• W2100082467 created "2016-06-24" @default.
• W2100082467 creator A5005471532 @default.
• W2100082467 creator A5026041640 @default.
• W2100082467 creator A5030616197 @default.
• W2100082467 creator A5034894419 @default.
• W2100082467 creator A5063435247 @default.
• W2100082467 creator A5066669117 @default.
• W2100082467 creator A5074550386 @default.
• W2100082467 creator A5074737892 @default.
• W2100082467 creator A5076340978 @default.
• W2100082467 creator A5090426246 @default.
• W2100082467 date "2012-11-07" @default.
• W2100082467 modified "2023-09-26" @default.
• W2100082467 title "Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model" @default.
• W2100082467 cites W1492340933 @default.
• W2100082467 cites W1951179504 @default.
• W2100082467 cites W1965505894 @default.
• W2100082467 cites W1972193434 @default.
• W2100082467 cites W1972848082 @default.
• W2100082467 cites W1977381580 @default.
• W2100082467 cites W1977917555 @default.
• W2100082467 cites W1981910809 @default.
• W2100082467 cites W1986593818 @default.
• W2100082467 cites W2003160783 @default.
• W2100082467 cites W2007138248 @default.
• W2100082467 cites W2008184262 @default.
• W2100082467 cites W2008790922 @default.
• W2100082467 cites W2026813736 @default.
• W2100082467 cites W2035671081 @default.
• W2100082467 cites W2040796340 @default.
• W2100082467 cites W2044098638 @default.
• W2100082467 cites W2053023721 @default.
• W2100082467 cites W2064830862 @default.
• W2100082467 cites W2065347473 @default.
• W2100082467 cites W2069898193 @default.
• W2100082467 cites W2075302864 @default.
• W2100082467 cites W2086071777 @default.
• W2100082467 cites W2096266806 @default.
• W2100082467 cites W2097692168 @default.
• W2100082467 cites W2112693092 @default.
• W2100082467 cites W2114993851 @default.
• W2100082467 cites W2116295027 @default.
• W2100082467 cites W2123363005 @default.
• W2100082467 cites W2130164253 @default.
• W2100082467 cites W2130465135 @default.
• W2100082467 cites W2142312775 @default.
• W2100082467 cites W2156330483 @default.
• W2100082467 cites W36517448 @default.
• W2100082467 doi "https://doi.org/10.1186/1479-5876-10-219" @default.
• W2100082467 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3543252" @default.
• W2100082467 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23134699" @default.
• W2100082467 hasPublicationYear "2012" @default.
• W2100082467 type Work @default.
• W2100082467 sameAs 2100082467 @default.
• W2100082467 citedByCount "22" @default.
• W2100082467 countsByYear W21000824672012 @default.
• W2100082467 countsByYear W21000824672013 @default.
• W2100082467 countsByYear W21000824672014 @default.
• W2100082467 countsByYear W21000824672015 @default.
• W2100082467 countsByYear W21000824672016 @default.
• W2100082467 countsByYear W21000824672017 @default.
• W2100082467 countsByYear W21000824672019 @default.
• W2100082467 countsByYear W21000824672020 @default.
• W2100082467 countsByYear W21000824672021 @default.
• W2100082467 countsByYear W21000824672022 @default.
• W2100082467 countsByYear W21000824672023 @default.
• W2100082467 crossrefType "journal-article" @default.
• W2100082467 hasAuthorship W2100082467A5005471532 @default.
• W2100082467 hasAuthorship W2100082467A5026041640 @default.
• W2100082467 hasAuthorship W2100082467A5030616197 @default.
• W2100082467 hasAuthorship W2100082467A5034894419 @default.
• W2100082467 hasAuthorship W2100082467A5063435247 @default.
• W2100082467 hasAuthorship W2100082467A5066669117 @default.
• W2100082467 hasAuthorship W2100082467A5074550386 @default.
• W2100082467 hasAuthorship W2100082467A5074737892 @default.
• W2100082467 hasAuthorship W2100082467A5076340978 @default.
• W2100082467 hasAuthorship W2100082467A5090426246 @default.
• W2100082467 hasBestOaLocation W21000824671 @default.
• W2100082467 hasConcept C142724271 @default.
• W2100082467 hasConcept C147483822 @default.
• W2100082467 hasConcept C150903083 @default.
• W2100082467 hasConcept C153911025 @default.
• W2100082467 hasConcept C159654299 @default.
• W2100082467 hasConcept C167672396 @default.
• W2100082467 hasConcept C185592680 @default.
• W2100082467 hasConcept C202751555 @default.
• W2100082467 hasConcept C203014093 @default.
• W2100082467 hasConcept C207001950 @default.
• W2100082467 hasConcept C2776090121 @default.
• W2100082467 hasConcept C2776652619 @default.
• W2100082467 hasConcept C2777331542 @default.
• W2100082467 hasConcept C2777658100 @default.
• W2100082467 hasConcept C2778707442 @default.
• W2100082467 hasConcept C2779134260 @default.
• W2100082467 hasConcept C502942594 @default.
• W2100082467 hasConcept C55493867 @default.
• W2100082467 hasConcept C71924100 @default.
• W2100082467 hasConcept C86803240 @default.
• W2100082467 hasConcept C8891405 @default.

• next